AI-guided peptide design

Unlocking the Full Therapeutic Potential of Peptides

SCROLL
OUR VISION

Peptides are among nature's most extraordinary molecules.

We are building a platform to advance promising peptide therapeutics, design entirely new molecules, and help partners address longstanding barriers to clinical development.

THE OPPORTUNITY

The Next Frontier in Peptide Therapeutics

Peptides are among biology's most versatile molecules, playing essential roles in many of the body's most important functions. They have already given rise to important medicines, yet much of their therapeutic potential remains unrealized.

Many promising peptides are unstable, short-lived, or difficult to deliver effectively. Advances in artificial intelligence and medicinal chemistry are creating new opportunities to overcome these challenges and expand what peptides can achieve.

Advancing Promising Peptides

Addressing the properties that have limited the development of biologically promising peptides, helping move them closer to viable therapeutic compounds.

Reimagining Existing Successes

Engineering known peptides to achieve a more balanced set of pharmacological properties and create novel molecular designs.

Designing New Molecules

Exploring entirely new peptide designs with combinatorial chemistry to expand possibilities.

OUR APPROACH

A New Era of Peptide Design

Peptaris is building an AI-powered platform to design peptides with the properties they need to become viable medicines.

PEPTIDE LEAD DESIGNSCORESYNTHESIZETEST APEXCHEM MODEL SUITE

Balance Multiple Properties at Once

We generate optimized candidates with targeted functional and developability properties.

Laboratory Data Generation

Our high-quality synthesis and experimental data libraries are architected for reliable model training.

A Continuous Learning System

The sophistication and accuracy of our molecular designs compound with every cycle.

Peptide chemistry in the laboratory
Experimental peptide chemistry
Model development on screen
Model development
OUR FOUNDATION

Built on Pioneering Science

Peptaris was founded by scientists from the University of Pennsylvania's Machine Biology Group and entrepreneurs with a shared ambition to advance the field of peptide design.

Building on research in AI-guided peptide discovery, our team brings together expertise in predicting how peptide sequences influence biological activity and engineering molecules with improved therapeutic properties.

Our ambition is to translate advances in molecular design and medicinal chemistry into the next generation of peptide medicines.

The Peptaris founding team
IN THE NEWS

News & Insights

All news

Discover the latest news from Peptaris and the pioneering research of our scientific founders.

CAREERS

Join Our Team

We are building an interdisciplinary team of scientists and engineers to advance the next generation of peptide design.

Join us at the intersection of artificial intelligence, chemistry, and biology, where ambitious ideas become scientific breakthroughs.

Open positionsSee where we are hiring View page
2300 Market Street, Philadelphia
WHERE WE ARE

Lilly Gateway Labs

2300 Market Street, Philadelphia, PA 19103

PARTNERSHIPS

Partner with us in advancing peptide science, and bringing its potential to the world.